 |  | | | |
| |
 |
Dr. Tom O’Bryan is a nationally recognized speaker specializing in Gluten Sensitivity and Celiac Disease. He is a clinician par excellence in treating chronic disease and metabolic disorders from a Functional Medicine Perspective. Board Certified in Nutrition, he is a graduate of the University of Michigan and the National Chiropractic College.
He holds Teaching Faculty positions with the Institute for Functional Medicine and The National University of Life Sciences. Dr. O’Bryan’s passion is in teaching the epidemic manifestations of Gluten Sensitivity and Celiac Disease as they occur outside of the intestines.
|
|
| |
 |
Chicago, Illinois
Saturday March 13, 2010 — Physician Lecture |
Oklahoma City, Oklahoma
Thursday April 15, 2010 — Public Lecture |
Tulsa, Oklahoma
Friday April 16, 2010 - Public Lecture
Saturday April 17, 2010 — Physician Lecture |
Austin, Texas
Friday May 5, 2010 — Public Lecture
Saturday May 6, 2010 — Physician Lecture |
Dallas, Texas
Dates To Be Announced |
Lexington, Kentucky
Dates To Be Announced |
 |
 |
|
| 9:00 AM — 9:30 AM |
| Walk attendees through both medicine’s historical and current understanding of Wheat/Gluten Sensitivity. |
| 9:30 AM — 10:00 AM |
| Explain the Differential Diagnosis of Celiac Disease,Wheat and Gluten Allergies, and Gluten Intolerance and Gluten Sensitivity. |
| 10:00 AM — 10:30 AM |
| Review the physiology of the auto-immune response in Gluten Sensitivity/Celiac Disease and its varied manifestations. |
| 10:30 AM — 10:45 AM Break |
| |
| 10:45 AM — 12:00 PM |
| Recognize the diversity of symptoms patients may present as a result of Wheat/Gluten sensitivity. |
| 12:00 — 1:00 PM Lunch (Lunch Provided) |
| |
| 1:00 PM — 2:30 PM |
| Review the clues in patients’ medical history, in-office examination findings, genetics and laboratory indicators in Celiac Disease and Gluten Sensitivity. |
| 2:45 PM — 5:00 PM |
| Become familiar with the dietary and nutraceutical effectiveness of treatment for the various presentations of Wheat and Gluten Sensitivity. Q & A. |
|
 |
| | | | |
|
|
